Pulmatrix Inc(NASDAQ : PULM)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Loading PULM News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.02%||70.47||1.0%||$913.76m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.43%||378.85||1.9%||$338.90m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.48%||133.19||2.0%||$303.71m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.43%||91.01||2.6%||$140.38m|
|CLVS||Clovis Oncology, Inc.||2.94%||59.51||16.4%||$119.33m|
|BMRN||BioMarin Pharmaceutical Inc.||0.39%||94.30||3.9%||$109.15m|
|A||Agilent Technologies, Inc.||1.25%||51.94||1.7%||$107.79m|
|ACAD||ACADIA Pharmaceuticals Inc.||-3.40%||36.82||19.0%||$93.82m|
Pulmatrix, Inc. is a clinical stage biotechnology company, which is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. It designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer in 2013 and is headquartered in Lexington, MA.